UC San Diego Health, the region’s only academic health system, is ranked #1 in San Diego and #5 in California, placing it among the nation’s best hospitals, according to the 2021-2022 U.S. News & World Report survey. UC San Diego Health was ranked in the top 50 in 10 specialties.
Senate President Pro Tempore Toni Atkins visited UC San Diego Medical Center today to recognize a $30 million allocation in the 2021-2022 California state budget that will support the redevelopment of the new Hillcrest hospital.
California legislators have allocated UC San Diego $35 million to design and build a new coastal research vessel with a first-of-its-kind hydrogen-hybrid propulsion system. The new vessel will be operated by Scripps Institution of Oceanography.
Gastroesophageal reflux disease, more commonly known as GERD, impacts around 20 percent of U.S. citizens, according to the National Institutes of Health. If left untreated, GERD can lead to serious medical issues and sometimes esophageal cancer.
UC San Diego researchers and their colleagues have discovered that spontaneous impulses of dopamine, the neurological messenger known as the brain’s “feel good” chemical, occur in the brain of mice. The study found that mice can willfully manipulate these random dopamine pulses for reward.
UC San Diego is one of six universities invited to participate in the Wu Tsai Human Performance Alliance, a scientific collaboration that aims to transform human health on a global scale through the discovery and translation of the biological principles underlying human performance.
UC San Diego computer music professor and high school student devise a machine learning tool to transfer music notation between musical styles.
Researchers at UC San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus that causes COVID-19, into the human brain.
Using anonymized medical records from a national registry, UC San Diego researchers confirm earlier findings that statins may substantially minimize adverse outcomes from SARS-CoV-2 infection.